Dissolution testing is an important aspect of drug development as it provides stability parameters and helps predict drug behavior in-vivo. For solid oral dosage forms, dissolution testing is a ...

PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced ...

Simcyp Limited announces that it has released the latest version of its flagship simulator, further cementing its position as the industry leader in modelling and simulation of drug-drug interactions ...

Princeton-based Certara, a model-informed drug development and decision support company, announced Wednesday it is celebrating the 20th anniversary of its Simcyp Consortium. According to Certara, the ...

PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 22, which includes new capabilities ...

Certara, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced the launch of version 18 of its Simcyp Population-based ...

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp Limited announces its acquisition (subject to certain closing conditions) by Certara, a leading provider of drug discovery and development software and ...

Nanosupensions are among the ways formulation scientists seek to address the problem of solubility. Strategies to improve drug solubility are of crucial importance to the pharmaceutical industry.

Announcing a new article publication for BIO Integration journal. Nitrofurantoin is a BCS II drug with a low solubility and dissolution rate. Therefore, the pharmaceutical applications of ...